12 years after it was approved for sale in India, government bans Buclizine drug1 min read 19 Dec 2018, 11:55 PM IST
The government notification dated 13 December, however, allowed the marketing of the drug for symptomatic treatment
New Delhi: The government has banned the use of the drug Buclizine as an appetite stimulant, almost 12 years after it was approved to be sold in India. Developed by Belgium-based UCB, the drug was being sold as syrups and tablets by Mankind Pharma in India.
Select your Category